Time to positivity in Staphylococcus aureus bacteremia:: Possible correlation with the source and outcome of infection

被引:116
作者
Khatib, R
Riederer, K
Saeed, S
Johnson, LB
Fakih, MG
Sharma, M
Tabriz, MS
Khosrovaneh, A
机构
[1] St John Hosp & Med Ctr, Dept Med, Infect Dis Sect, Detroit, MI 48236 USA
[2] Wayne State Univ, Sch Med, Detroit, MI USA
关键词
D O I
10.1086/432472
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Staphylococcus aureus bacteremia often persists and causes metastatic infections. It is unknown whether the time between blood culture incubation and growth detection (i.e., the time to positivity) in a continuously monitored system - a probable surrogate marker of bacteremia severity - correlates with outcome. Methods. We performed a prospective, observational study involving adult inpatients who had S. aureus bacteremia between 1 January 2002 and 30 June 2003 at a 600-bed teaching hospital. Measurements included time to positivity in initial blood culture series, duration of bacteremia, rate of metastatic infection, and outcome. Results. A total of 376 S. aureus bacteremias (>= 1 positive blood culture result) were reported for 357 patients aged 18 - 103 years (median age, 59 years); 64 bacteremias were excluded because blood was drawn after antibiotic therapy was started (n = 59) or through an intravascular catheter (n = 5). The source of infection was identified in 244 series (78.2%). Metastatic infection was detected in 25 bacteremias (8.0%). The mortality rate was 25.6%. The duration of bacteremia (determined in 251 series) was 1 - 59 days (median duration, 1 day; 70th percentile, 3 days). The time to positivity ranged from 4.2 to 98.2 h (median time to positivity, 15.5 h) and was significantly shorter for patients with an endovascular source of infection (14.9 +/- 5.4 vs. 19.5 +/- 10.6 P < .0005 h;), extended duration (i.e., >= 3 days) of bacteremia (14.1 +/- 4.2 vs. 18.6 +/- 9.2 h; P < .0005), and metastatic infection (12.9 +/- 5.9 vs 18.0 +/- 9.3 h; P = .007). Analysis of a range of cutoff values demonstrated that a time to positivity of <= 14 h yielded the best sensitivity and specificity for predicting the source and outcome of infection. Logistic regression analyses revealed that a time to positivity of <= 14 h was an independent predictor of an endovascular source of infection (P < .0005), extended bacteremia (P < .0005), metastatic infection (P < .0005), and attributable mortality (P = .017). Conclusions. Time to positivity in S. aureus bacteremia may provide useful diagnostic and prognostic information. Growth of S. aureus within 14 h after the initiation of incubation may identify patients with a high likelihood of endovascular infection sources, delayed clearance, and complications.
引用
收藏
页码:594 / 598
页数:5
相关论文
共 50 条
  • [41] Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer
    González-Barca, E
    Carratalà, J
    Mykietiuk, A
    Fernández-Sevilla, A
    Gudiol, F
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (02) : 117 - 119
  • [42] Predisposing Factors and Outcome of Staphylococcus aureus Bacteremia in Neutropenic Patients with Cancer
    E. González-Barca
    J. Carratalá
    A. Mykietiuk
    A. Fernández-Sevilla
    F. Gudiol
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 : 117 - 119
  • [43] Pediatric and Neonatal Staphylococcus aureus Bacteremia: Epidemiology, Risk Factors, and Outcome
    Burke, Robert E.
    Halpern, Meira S.
    Baron, Ellen Jo
    Gutierrez, Kathleen
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (07) : 636 - 644
  • [44] Staphylococcus aureus Bacteremia in the Pediatric Emergency Department and Predictors of Poor Outcome
    Suarez-Bustamante Huelamo, Maria
    Alonso-Cadenas, Jose Antonio
    Cortes, Borja Gomez
    Goikoetxea, Iker Gangoiti
    Hernandez-Bou, Susanna
    de la Torre Espi, Mercedes
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (11) : 954 - 959
  • [45] DEVASTATING METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA WITH AN UNKNOWN SOURCE
    Kagita, Navyamani V.
    Thota, Vihitha
    Jain, Akhil
    Ikoro, Udunma N.
    Sheu, Wei-Chun
    Russell, Steven
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S324 - S324
  • [46] Clinical characteristics and outcomes of Staphylococcus aureus bacteremia from a biliary source
    Eunmi Yang
    Jeongsoo Lee
    Hyeonji Seo
    Hyemin Chung
    Sang Hyun Ra
    Heungsup Sung
    Mi-Na Kim
    Jiwon Jung
    Min Jae Kim
    Sung-Han Kim
    Sang-Oh Lee
    Sang-Ho Choi
    Jun Hee Woo
    Yang Soo Kim
    Yong Pil Chong
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 1951 - 1957
  • [47] Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?
    Mourad, Ahmad
    Holland, Thomas L.
    Turner, Nicholas A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [48] Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia
    Jung, Jiwon
    Lee, Junyeop
    Yu, Shi Nae
    Kim, Yong Kyun
    Lee, Ju Young
    Sung, Heungsup
    Kim, Mi-Na
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Woo, Jun Hee
    Lee, Joo Yong
    Kim, Yang Soo
    Chong, Yong Pil
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2012 - 2017
  • [49] Cardiovascular Implantable Electronic Device Infection in Patients with Staphylococcus aureus Bacteremia
    Uslan, Daniel Z.
    Dowsley, Taylor F.
    Sohail, Muhammad R.
    Hayes, David L.
    Friedman, Paul A.
    Wilson, Walter R.
    Steckelberg, James M.
    Baddour, Larry M.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (04): : 407 - 413
  • [50] Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection
    Falces-Romero, Iker
    Bloise, Ivan
    Garcia-Rodriguez, Julio
    Cendejas-Bueno, Emilio
    [J]. MEDICINA CLINICA, 2023, 160 (11): : 495 - 498